Diseases, Conditions, Syndromes

New study provides data on protections of Ebola vaccines

A new study published in Science Translational Medicine reports on the Ebola vaccine-mediated protection of five mucosal vaccine vectors based on the human and avian paramyxoviruses. The study comprehensively characterized ...

Diseases, Conditions, Syndromes

DNA vaccines for COVID-19 effective in mice, hamsters

Currently available COVID-19 vaccines rely on mRNA strands to teach the human immune system to recognize the SARS-CoV-2 virus. Now, researchers reporting in PLOS Neglected Tropical Diseases have reported the successful development ...

Diseases, Conditions, Syndromes

Man's Ebola relapse spawned dozens of new cases in Africa

A man in Africa who developed Ebola despite receiving a vaccine recovered but suffered a relapse nearly six months later that led to 91 new cases before he died. The report adds to evidence that the deadly virus can lurk ...

Diseases, Conditions, Syndromes

Antibody highs and lows in survivors of Ebola

A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found.

Diseases, Conditions, Syndromes

Single-cell study of Ebola highlights virus's lethal maneuvers

Ebola virus is one of the world's deadliest pathogens, and scientists now report new details of how the virus alters the host immune response for its own benefit during infection. In a study published today in Cell, the researchers ...

page 3 from 40